Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 758-760

  Hashimoto, Naoki ^a   Inayama, Masato ^a   Fujishima, Makoto ^a   Shiozaki, Hitoshi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Squamous cell carcinoma; Strong; Weak

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34250198225     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Greenlee RT, Hill Harmon MB, Murray T, et al: Cancer Statistics 2001. CA-cancer J Clin 2001; 51:15-36.
2. Thun MJ, Namboodiri MM, Calle EE, et al: Aspirin use and risk of fatal cancer. Cancer Res 1993; 53:1322-1327.
3. Lagergreen J, Bergstrom R, Lindgren A, et al: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Eng J Med 1999; 34:828-831.
4. Yamaguchi T, Watanabe M, Kubota T, et al: Cyclo-oxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum 2002; 45:98-103.
5. Zimmer KC, Sarbia M, Weber AA, et al: Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59:198-204.
6. Japanese Society for Esophageal Diseases: Guidelines for the clinical and Pathological Studies on Carcinoma of the Esophagus. 9th Edition. Tokyo: Kanehara Company, 1999.
7. Sobin LH, Wittekind C: TNM Classification of malignant Tumors. In: International Union Against Cancer. 5th Edition. New York: Wiley-Liss, 1977; pp. 54-58.
8. Zimmermann KC, Sarbia M, Weber AA, et al: Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59:198-204.
9. Kase S, Osaki M, Honjo S, et al: Expression of COX2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinoma. Virchows Arch 2003; 442:129-135.
10. Kagoura M, Toyoda M, Matui C, et al: Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J Cutan Pathol 2001; 28:298-302.
11. Ranelletti FO, Almadori G, Rocca B, et al: Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 2001; 95:343-349.
12. Wolff H, Saukkonen K, Anttila S, et al: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998; 58:4997-5001.
13. Gaffney DK, Holden J, Davis M, et al: Cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49:1213-1217.
14. Ratnasinghe D, Tangrea J, Roth MJ, et al: Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res 1999; 19:171-174.
15. Chen YJ, Wang LS, Wang PH, et al: High cyclooxygenase-2 expression in cervical adenocarcinomas. Gynecol Oncol 2003; 88:379-385.
16. Kawamori T, Rao CV, Seibert K, et al: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58:409-412.